These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3093295)

  • 1. Long-term treatment of angina pectoris with carteolol: a new beta-adrenergic receptor blocking agent.
    Luther RR; Glassman HN; Jordan DC; Klepper MJ
    J Int Med Res; 1986; 14(4):167-74. PubMed ID: 3093295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of angina pectoris with the new beta-receptor blocker carteolol. Results of a controlled trial in comparison with pindolol.
    Simon H; Schuppan U
    Arzneimittelforschung; 1983; 33(2a):318-21. PubMed ID: 6340700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of carteolol and nadolol in the treatment of stable angina pectoris.
    Luther RR; Glassman HN; Jordan DC
    J Clin Pharmacol; 1988 Jul; 28(7):634-9. PubMed ID: 3063728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical experiences in patients with coronary heart disease and angina pectoris].
    Sölter H
    Arzneimittelforschung; 1983; 33(2a):304-10. PubMed ID: 6404286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carteolol treatment of essential hypertension: a long-term study of safety and efficacy.
    Luther RR; Maurath CJ; Klepper MJ; Peckinpaugh RO; Ringham GL
    J Int Med Res; 1986; 14(4):175-84. PubMed ID: 3758467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparative study of carteolol and propranolol on exercise performance in patients with chronic stable angina pectoris].
    Liu PH; Lai WY; Chen CY; Shieh SM
    Taiwan Yi Xue Hui Za Zhi; 1985 Apr; 84(4):457-61. PubMed ID: 3860617
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G; Veidt J; Mikludy R; Kaltenbach M
    Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atenolol: once-daily cardioselective beta blockade for angina pectoris.
    Jackson G; Schwartz J; Kates RE; Winchester M; Harrison DC
    Circulation; 1980 Mar; 61(3):555-60. PubMed ID: 6243518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Carteolol in essential hypertension. Dose range study and controlled open trial in comparison with pindolol].
    Werning C
    Arzneimittelforschung; 1983; 33(2a):325-30. PubMed ID: 6682324
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose related efficacy of betaxolol in combination with nitroglycerin in patients with angina pectoris: a double blind cross-over study.
    Stroobandt R; Kesteloot H
    Arch Int Pharmacodyn Ther; 1984 Feb; 267(2):299-309. PubMed ID: 6143538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term treatment with low doses of carteolol on cardiovascular regulatory functions in elderly patients with mild hypertension.
    Shimada K; Kawamoto A; Matsubayashi K; Chikamori T; Kuzume O; Ozawa T
    Clin Ther; 1990; 12(2):118-24. PubMed ID: 1972351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C; Romanet JP; Nordmann JP; Allaire C;
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of intrinsic sympathomimetic activity of the beta blocker carteolol. II: Comparative studies of carteolol and pindolol in patients with bradycardia].
    Lohmöller G; Middeke M; Mrowka C; Pötzl C; Renner W; Zoller W
    Med Klin (Munich); 1989 Feb; 84(2):81-5. PubMed ID: 2651861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.
    Tarkiainen A; Saraste K; Seppälä T; Gordin A; Auvinen J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):239-44. PubMed ID: 6116605
    [No Abstract]   [Full Text] [Related]  

  • 16. [Carteolol: general practice-oriented assessment of the effectiveness and tolerance of a new beta-blocker in the treatment of glaucoma].
    Schnaudigel OE; Becker H; Fuchs HB
    Klin Monbl Augenheilkd; 1988 Mar; 192(3):248-51. PubMed ID: 3374015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops].
    Flury H; Tournoux A; Martenet AC
    Klin Monbl Augenheilkd; 1986 Jun; 188(6):573-5. PubMed ID: 3761959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carteolol and penbutolol for hypertension.
    Med Lett Drugs Ther; 1989 Jul; 31(797):70-1. PubMed ID: 2568577
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of atenolol on treadmill performance in patients with angina pectoris.
    Kritzer G; Warr TA; Strong ML; Froelicher VF
    Clin Pharm; 1983; 2(3):236-42. PubMed ID: 6349909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical results with carteolol in patients with arrhythmias].
    Strösser W
    Arzneimittelforschung; 1983; 33(2a):339-45. PubMed ID: 6682327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.